GROα promotes invasion of colorectal cancer cells

Oncology Reports

Volumn 24, Issue 6, 2010, Pages 1479-1486

  Ogata, Hideo ^a   Sekikawa, Akira ^a   Yamagishi, Hidetsugu ^a   Ichikawa, Kazuhito ^a   Tomita, Shigeki ^a   Imura, Johji ^a   Ito, Yuichi ^a   Fujita, Masanori ^a   Tsubaki, Masahiro ^a   Kato, Hiroyuki ^a   Fujimori, Takahiro ^a   Fukui, Hirokazu ^a,b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; CXCR2; Growth regulated oncogene ; Invasion

Indexed keywords

GENE PRODUCT; GROWTH REGULATED ONCOGENE ALPHA; MATRIGEL; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CXCR2 GENE; FEMALE; GENE EXPRESSION; GROALPHA GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CACO-2 CELLS; CELL PROLIFERATION; CHEMOKINE CXCL1; COLORECTAL NEOPLASMS; FEMALE; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 78649429469     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001008     Document Type: Article

References (54)

1. Baggiolini M: Chemokines and leukocyte traffic. Nature 392: 565-568, 1998.
2. Rollins BJ: Chemokines. Blood 90: 909-928, 1997.
3. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.
4. Rossi D and Zlotnik A: The biology of chemokines and their receptors. Ann Rev Immunol 18: 217-242, 2000.
5. Gillitzer R and Goebeler M: Chemokines in cutaneous wound healing. J Leukoc Biol 69: 513-521, 2001.
6. Mackay CR: Chemokines: immunology's high impact factors. Nat Immunol 2: 95-101, 2001.
7. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 4: 540-550, 2004.
8. Ruffini PA, Morandi P, Cabioglu N, Altundag K and Cristofanilli M: Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer 109: 2392-2404, 2007.
9. Koizumi K, Hojo S, Akashi T, Yasumoto K and Saiki I: Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 98: 1652-1658, 2007.
10. Anisowicz A, Bardwell L and Sager R: Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci USA 84: 7188-7192, 1987.
11. Nanney LB, Muller SG, Bueno R, Peiper SC and Richmond A: Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am J Pathol 147: 1248-1260, 1995.
12. Ahuja SK and Philip MM: The CXC chemokines growthregulated oncogene (GRO) α, GROß, GROγ, neutrophil-activating peptide-2, and epithelial cell-derived neutophilactivating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271: 20545-20550, 1996.
13. Rennekampff HO, Hansbrough JF, Woods V Jr, Doré C, Kiessig V and Schröder JM: Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch Dermatol Res 289: 204-212, 1997.
14. Richmond A, Lawson DH, Nixon DW and Chawla RK: Characterization of autostimulatory and transforming growth factors from human melanoma cells. Cancer Res 45: 6390-6394, 1985.
15. Dhawan P and Richmond A: Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 72: 9-18, 2002.
16. Zhou Y, Zhang J, Liu Q, Bell R, Muruve DA, Forsyth P, Arcellana-Panlilio M, Robbins S and Yong VW: The chemokine GRO-α (CXCL1) confers increased tumorigenicity to glioma cells. Carcinogenesis 26: 2058-2068, 2005.
17. Li J and Sidell N: Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase. Int J Cancer 117: 14-20, 2005.
18. Vazquez-Martin A, Colomer R and Menendez JA: Protein array technology to detect HER (erb-2)-induced cytokine signature in breast cancer. Eur J Cancer 43: 1117-1124, 2007.
19. Bachmeier BE, Mohrenz IV, Mirisola V, Schleicher E, Romeo F, Höhneke C, Jochum M, Nerlich AG and Pfeffer U: Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFκB. Carcinogenesis 29: 779-789, 2008.
20. Yang G, Rossen DG, Zhang Z, Bast RC Jr, Mills GB, Colacino JA, Mercado I and Liu J: The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 103: 16472-16477, 2006.
21. Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD and Strieter RM: Distinct CX chemokines mediates tumorigenicity of prostate cancer cell. Am J Pathol 154: 1503-1512, 1999.
22. Engl T, Relja B, Blumenberg C, Müller I, Ringel EM, Beecken WD, Jonas D and Blaheta RA: Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix. Life Sci 78: 1784-1793, 2006.
23. Kawanishi H, Matsui Y, Ito M, Watanabe J, Takahashi T, Nishizawa K, Nishiyama H, Kamoto T, Mikami Y, Tanaka Y, Jung G, Akiyama H, Nobumasa H, Guilford P, Reeve A, Okuno Y, Tsujimoto G, Nakamura E and Ogawa O: Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res 14: 2579-2587, 2008.
24. Notterman DA, Alon U, Sierk AJ and Levine AJ: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130, 2001.
25. Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E and Becerra C: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003.
26. Wen Y, Giardina SF, Hamming D, Greenman J, Zachariah E, Bacolod MD, Liu H, Shia J, Amenta PS, Barany F, Paty P, Gerald W and Notterman D: GROα is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res 12: 5951-5959, 2006.
27. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK and DuBois RN: CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 203: 941-951, 2006.
28. Sekikawa A, Fukui H, Fujii S, Takeda J, Nanakin A, Hisatsune H, Seno H, Takasawa S, Okamoto H, Fujimori T and Chiba T: REG Iα protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 128: 642-653, 2005.
29. Fukui H, Fujii S, Takeda J, Kayahara T, Sekikawa A, Nanakin A, Suzuki K, Hisatsune H, Seno H, Sawada M, Fujimori T and Chiba T: Expression of Reg Iα protein in human gastric cancers. Digestion 69: 177-184, 2004. (Pubitemid 38813027)
30. Gerard C and Rollins BJ: Chemokines and disease. Nat Immunol 2: 108-115, 2001.
31. Rubie C, Frick VO, Wagner M, Schuld J, Gräber S, Brittner B, Bohle RM and Schilling MK: ELR+ CXC chemokine expression in benign and malignant colorectal conditions. BMC cancer 8: 178, 2008.
32. Leber MF and Efferth T: Molecular principles of cancer invasion and metastasis. Int J Oncol 34: 881-895, 2009.
33. Leeman MF, Curran S and Murray G: New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201: 528-534, 2003.
34. Kakinuma T and Hwang ST: Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79: 639-651, 2006.
35. Tang CH, Tan TW, Fu WM and Yang RS: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/ CXCR4 pathway of lung cancer metastasis. Carcinogenesis 29: 35-43, 2008.
36. + myeloid cells that promote invasion. Nat Genet 39: 467-475, 2007.
37. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblast present in invasive human breast carcinoma promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005.
38. Salmaggi A, Gelati B, Pollo B, Marras C, Silvani A, Balestrini MR, Eoli M, Fariselli L, Broggi G and Boiardi A: CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. J Neurooncol 74: 287-293, 2005.
39. Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G and Castello G: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 11: 1835-1841, 2005.
40. Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D and Hung MC: Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6: 459-469, 2004.
41. Müller A, Homey B, Soto H, Ge N, Carton D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
42. Spano JP, Andre F, Morat L, Sabatier L, Besse B, Combadiere C, Deterre P, Martin A, Azorin J, Valeyre D, Khayat D, Chevalier TL and Soria JC: Chemokine receptor CXCR4 and early-stage non-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15: 613-617, 2004.
43. Yoshitake N, Fukui H, Yamagishi H, Sekikawa A, Fujii S, Tomita S, Ichikawa K, Imura J, Hiraishi H and Fujimori T: Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98: 1682-1689, 2008.
44. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ and Hoon DS: Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23: 2744-2753, 2005.
45. Yan W and Chen X: Identification of GRO1 as a critical determinant for mutant p53 gain of function. J Biol Chem 284: 12178-12187, 2009.
46. Soussi T: The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 910: 121-139, 2000.
47. Murakami T, Maki W, Cardones AR, Fang H, Kyi AT, Nestle FO and Hwang ST: Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62: 7328-7334, 2002.
48. Takenaga M, Tamamura H, Hiramatsu K, Nakamura N, Yamaguchi Y, Kitagawa A, Kawai S, Nakashima H, Fujii N and Igarashi R: A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulamonary metastasis of murine melanoma. Biochem Biophys Res Commun 320: 226-232, 2004.
49. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-565, 2007.
50. Liang Z, Wu T, Lou H, Yu W, Taichman RS, Lau SK, Nie S, Umbreit J and Shim H: Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64: 4302-4308, 2004.
51. Walser TC, Rifat S, Ma X, Kundu N, Ward C, Goloubeva O, Johnson MG, Medina JC, Collins TL and Fulton AM: Antagonist of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res 66: 7701-7707, 2006.
52. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M and Omata M: Blockade of the stromal cell-derived factor-1/ CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65: 5864-5871, 2005.
53. Cambien B, Karimdjee BF, Richard-Fiardo P, Bziouech H, Barthel R, Millet MA, Martini V, Birnbaum D, Scoazec JY, Abello J, Al Saati T, Johnson MG, Sullivan TJ, Medina JC, Collins TL, Schmid-Alliana A and Schmid-Antomarchi H: Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonist. Br J Cancer 100: 1755-1764, 2009.
54. Yamamoto M, Kikuchi H, Ohta M, Kawabata T, Hiramatsu Y, Kondo K, Baba M, Kamiya K, Tanaka T, Kitagawa M and Konno H: TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res 68: 9754-9762, 2008.